A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans

Psychopharmacology

Volumn 219, Issue 1, 2012, Pages 109-122

  Kirkpatrick, Matthew G ^a,b,c   Gunderson, Erik W ^b   Perez, Audrey Y ^b   Haney, Margaret ^b   Foltin, Richard W ^b   Hart, Carl L ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Amphetamines; Food intake; Humans; MDMA; Methamphetamine; Psychomotor performance; Sleep; Subjective effects

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; METHAMPHETAMINE; PLACEBO;

ADULT; ARTICLE; BEHAVIOR CHANGE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EUPHORIA; FEMALE; FOOD INTAKE; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; MOOD CHANGE; PHYSIOLOGICAL PROCESS; PREDICTION; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RESIDUE ANALYSIS; SLEEP DEPRIVATION; SYSTOLIC BLOOD PRESSURE; TEMPERATURE SENSITIVITY;

ADMINISTRATION, ORAL; ADULT; COGNITION; EATING; FEMALE; HUMANS; MALE; METHAMPHETAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PSYCHOMOTOR PERFORMANCE; SLEEP; YOUNG ADULT;

EID: 84856684640     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2383-4     Document Type: Article

References (58)

1. K Allott J Redman 2006 Patterns of use and harm reduction practices of ecstasy users in Australia Drug Alcohol Depend 82 168 176 16226850 10.1016/j.drugalcdep.2005.09.009
2. K Baicy ED London 2007 Corticolimbic dysregulation and chronic methamphetamine abuse Addiction 102 Suppl 1 5 15 17493049 10.1111/j.1360-0443. 2006.01777.x (Pubitemid 46328215)
3. G Bedi D Hyman H de Wit 2010 Is ecstasy an "empathogen"? Effects of 3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others Biol Psychiatry 68 1134 1140 20947066 10.1016/j.biopsych.2010.08.003 1:CAS:528:DC%2BC3cXhsFWqtbnN
4. KI Bolla UD McCann GA Ricaurte 1998 Memory impairment in abstinent MDMA ("ecstasy") users Neurology 51 1532 1537 9855498 1:CAS:528: DyaK1MXhsVOntw%3D%3D
5. J Cami M Farre M Mas PN Roset S Poudevida A Mas L San R de la Torre 2000 Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects J Clin Psychopharmacol 20 455 466 10917407 10.1097/00004714-200008000-00010 1:CAS:528:DC%2BD3cXlsFymtLo%3D (Pubitemid 30463762)
6. AK Cho WP Melega R Kuczenski DS Segal 2001 Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse Synapse 39 161 166 11180503 10.1002/1098-2396(200102)39:2<161::AID-SYN7>3.0.CO;2-E 1:CAS:528:DC%2BD3MXpsFah (Pubitemid 32104021)
7. SD Comer M Haney RW Foltin MW Fischman 1996 Amphetamine self-administration by humans: modulation by contingencies associated with task performance Psychopharmacology 127 39 46 8880942 10.1007/BF02805973 1:CAS:528:DyaK28Xlslanurs%3D (Pubitemid 26285681)
8. SD Comer CL Hart AS Ward M Haney RW Foltin MW Fischman 2001 Effects of repeated oral methamphetamine administration in humans Psychopharmacology 155 397 404 11441429 10.1007/s002130100727 1:CAS:528:DC%2BD3MXkvFShurc%3D (Pubitemid 32523110)
9. CE Cook AR Jeffcoat BM Sadler JM Hill RD Voyksner DE Pugh WR White M Perez-Reyes 1992 Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans Drug Metab Dispos 20 856 862 1362938 1:CAS:528:DyaK3sXjt1CrtA%3D%3D
10. CE Cook AR Jeffcoat JM Hill DE Pugh PK Patetta BM Sadler WR White M Perez-Reyes 1993 Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride Drug Metab Dispos 21 717 723 8104133 1:CAS:528:DyaK3sXmtFKksr8%3D (Pubitemid 23221770)
11. RD Crean SA Davis SN Von Huben CC Lay SN Katner MA Taffe 2006 Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques Neuroscience 142 515 525 16876329 10.1016/j.neuroscience.2006.06.033 1:CAS:528: DC%2BD28XpvFSjs7g%3D (Pubitemid 44430041)
12. H de Wit S Dudish J Ambre 1993 Subjective and behavioral effects of diazepam depend on its rate of onset Psychopharmacology 112 324 330 7871037 10.1007/BF02244928 (Pubitemid 23278296)
13. RW Foltin MW Fischman MF Byrne 1988 Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory Appetite 11 1 14 3228283 10.1016/S0195-6663(88)80017-5 1:STN:280:DyaL1M7kvFSltg%3D%3D
14. RW Foltin BJ Rolls TH Moran TH Kelly AL McNelis MW Fischman 1992 Caloric, but not macronutrient, compensation by humans for required-eating occasions with meals and snack varying in fat and carbohydrate Am J Clin Nutr 55 331 342 1734669 1:STN:280:DyaK387jtlGgtg%3D%3D
15. DJ Grelotti G Kanayama HG Pope Jr 2010 Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature Am J Psychiatry 167 17 23 20068123 10.1176/appi.ajp.2009.08111695
16. PN Halkitis BN Fischgrund JT Parsons 2005 Explanations for methamphetamine use among gay and bisexual men in New York City Subst Use Misuse 40 1331 1345 16048820 10.1081/JA-200066900 (Pubitemid 41098796)
17. DT Hamamoto NL Rhodus 2009 Methamphetamine abuse and dentistry Oral Dis 15 27 37 18992021 10.1111/j.1601-0825.2008.01459.x 1:STN:280: DC%2BD1M%2FitVKitg%3D%3D
18. M Haney SD Comer MW Fischman RW Foltin 1997 Alprazolam increases food intake in humans Psychopharmacology 132 311 314 9292632 10.1007/s002130050350 1:CAS:528:DyaK2sXlsVGqsrw%3D (Pubitemid 27351433)
19. M Haney AS Ward SD Comer CL Hart RW Foltin MW Fischman 2001 Bupropion SR worsens mood during marijuana withdrawal in humans Psychopharmacology 155 171 179 11401006 10.1007/s002130100725 1:CAS:528:DC%2BD3MXlslKqsrw%3D (Pubitemid 32523103)
20. M Haney EW Gunderson J Rabkin CL Hart SK Vosburg SD Comer RW Foltin 2007 Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood and sleep JAIDS 45 545 554 17589370 10.1097/QAI.0b013e31811ed205 1:CAS:528:DC%2BD2sXps1ahs7o%3D (Pubitemid 47294927)
21. CL Hart AS Ward M Haney RW Foltin MW Fischman 2001 Methamphetamine self-administration by humans Psychopharmacology 157 75 81 11512046 10.1007/s002130100738 1:CAS:528:DC%2BD3MXnsVelsLc%3D (Pubitemid 32758962)
22. CL Hart M Haney RW Foltin MW Fischman 2002 Effects of the NMDA antagonist memantine on human methamphetamine discrimination Psychopharmacology 164 376 384 12457267 10.1007/s00213-002-1225-9 1:CAS:528:DC%2BD38XptFehsr4%3D (Pubitemid 35435713)
23. CL Hart AS Ward M Haney J Nasser RW Foltin 2003 Methamphetamine attenuates disruptions in performance and mood during simulated night-shift work Psychopharmacology 169 42 51 12734635 10.1007/s00213-003-1464-4 1:CAS:528:DC%2BD3sXmsFaru7g%3D (Pubitemid 37088613)
24. CL Hart EW Gunderson A Perez MG Kirkpatrick A Thurmond SD Comer RW Foltin 2008 Acute physiological and behavioral effects of intranasal methamphetamine in humans Neuropsychopharmacology 33 1847 1855 17851535 10.1038/sj.npp.1301578 1:CAS:528:DC%2BD1cXntFShs74%3D (Pubitemid 351832594)
25. DK Hatsukami MW Fischman 1996 Crack cocaine and cocaine hydrochloride. Are the differences myth or reality? JAMA 276 1580 1588 8918856 10.1001/jama.1996.03540190052029 1:CAS:528:DyaK28XnsValt7w%3D (Pubitemid 26384741)
26. Holland J (2001) Ecstasy: the complete guide: a comprehensive look at the risks and benefits of MDMA. Park Street Press, Rochester, VT
27. R Hoshi K Mullins C Boundy C Brignell P Piccini HV Curran 2007 Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls Psychopharmacology 194 371 379 17605005 10.1007/s00213-007-0837-5 1:CAS:528:DC%2BD2sXhtVWqu7rM (Pubitemid 47389342)
28. CE Johanson M Kilbey K Gatchalian M Tancer 2006 Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo Drug and Alcohol Dependence 81 27 36 15975736 10.1016/j.drugalcdep.2005.05.003 1:CAS:528:DC%2BD2MXht1Onur7E (Pubitemid 41682476)
29. HE Jones BE Garrett RR Griffiths 2001 Reinforcing effects of oral cocaine: contextual determinants Psychopharmacology 154 143 152 11314676 10.1007/s002130000626 1:CAS:528:DC%2BD3MXitlSlsrw%3D (Pubitemid 32186499)
30. TH Kelly RW Foltin CS Emurian MW Fischman 1993 Performance-based testing for drugs of abuse: dose and time profiles of marijuana, amphetamine, alcohol, and diazepam J Anal Toxicol 17 264 272 8107459 1:CAS:528:DyaK2cXitlel (Pubitemid 23252135)
31. BC Kelly JT Parsons BE Wells 2006 Prevalence and predictors of club drug use among club-going young adults in New York City J Urban Health 83 884 895 16937088 10.1007/s11524-006-9057-2 (Pubitemid 44310355)
32. CA Kushida A Chang C Gadkary C Guilleminault O Carrillo WC Dement 2001 Comparison of actigraphic, polysomnographic, and subjective assessment of sleep parameters in sleep-disordered patients Sleep Med 2 389 396 14592388 10.1016/S1389-9457(00)00098-8 1:STN:280:DC%2BD3srhtFGjtA%3D%3D (Pubitemid 32952342)
33. KP Kuypers JG Ramaekers 2005 Transient memory impairment after acute dose of 75 mg 3.4-Methylene-dioxymethamphetamine J Psychopharmacol 19 633 639 16272186 10.1177/0269881105056670 1:CAS:528:DC%2BD2MXht1Kru77E (Pubitemid 41578826)
34. ME Liechti MA Geyer D Hell FX Vollenweider 2001 Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin Neuropsychopharmacology 24 240 252 11166515 10.1016/S0893-133X(00)00199-8 1:CAS:528:DC%2BD3MXpsFSjug%3D%3D (Pubitemid 32144810)
35. M Lyvers 2006 Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues Drug Alcohol Rev 25 269 276 16753651 10.1080/09595230600657758 (Pubitemid 43841696)
36. GF Marrone JS Pardo RM Krauss CL Hart 2010 Amphetamine analogs methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) differentially affect speech Psychopharmacology 208 169 177 19916063 10.1007/s00213-009-1715-0 1:CAS:528:DC%2BD1MXhsVWmsL3I
37. DR McLeod RR Griffiths GE Bigelow J Yingling 1982 An automated version of the digit symbol substitution test (DSST) Behav Res Meth Instrum 14 463 436 10.3758/BF03203313
38. TP Miller JL Taylor JR Tinklenberg 1988 A comparison of assessment techniques measuring the effects of methylphenidate, secobarbital, diazepam and diphenhydramine in abstinent alcoholics Neuropsychobiology 19 90 96 3226529 10.1159/000118441 1:STN:280:DyaL1M7ksVSitQ%3D%3D
39. RC Mohs JR Tinklenberg WT Roth BS Kopell 1978 Methamphetamine and diphenhydramine effects on the rate of cognitive processing Psychopharmacology 59 13 19 100808 10.1007/BF00428024 1:CAS:528:DyaE1cXlvFWhtb0%3D (Pubitemid 9013399)
40. M Mueller EA Kolbrich FT Peters HH Maurer UD McCann MA Huestis GA Ricaurte 2009 Direct comparison of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") disposition and metabolism in squirrel monkeys and humans Ther Drug Monit 31 367 373 19417716 10.1097/FTD.0b013e3181a4f6c2 1:CAS:528:DC%2BD1MXmt1ejtLY%3D
41. AC Parrott J Lasky 1998 Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance Psychopharmacology 139 261 268 9784083 10.1007/s002130050714 1:CAS:528:DyaK1cXmtlygsLs%3D (Pubitemid 28439526)
42. GA Perez M Haney RW Foltin CL Hart 2008 Modafinil decreases food intake in humans subjected to simulated shift work Pharmacol Biochem Behav 90 717 722 18573275 10.1016/j.pbb.2008.05.018 1:CAS:528:DC%2BD1cXhtVClurbK
43. AY Perez MG Kirkpatrick EW Gunderson G Marrone R Silver RW Foltin CL Hart 2008 Residual effects of intranasal methamphetamine on sleep, mood, and performance Drug Alcohol Depend 94 258 262 18078723 10.1016/j.drugalcdep.2007. 10.011 1:CAS:528:DC%2BD1cXisVWhsr0%3D
44. SJ Peroutka H Newman H Harris 1988 Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users Neuropsychopharmacology 1 273 277 2908020 1:STN:280:DyaL1M3os1yksA%3D%3D (Pubitemid 19126146)
45. S Randall CE Johanson M Tancer T Roehrs 2009 Effects of acute 3,4-methylenedioxymethamphetamine on sleep and daytime sleepiness in MDMA users: a preliminary study Sleep 32 1513 1519 19928391
46. J Rodgers T Buchanan C Pearson AC Parrott J Ling TM Hefferman AB Scholey 2006 Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study J Psychopharmacol 20 437 446 16174668 10.1177/0269881105058777
47. RB Rothman MH Baumann CM Dersch DV Romero KC Rice FI Carroll JS Partilla 2001 Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin Synapse 39 32 41 11071707 10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3 1:CAS:528:DC%2BD3cXovFahsLg%3D
48. BY Silber RJ Croft K Papafotiou C Stough 2006 The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance Psychopharmacology 187 154 169 16761129 10.1007/s00213-006-0410-7 1:CAS:528:DC%2BD28Xms1Gqur8%3D (Pubitemid 44015610)
49. K Silverman KC Kirby RR Griffiths 1994 Modulation of drug reinforcement by behavioral requirements following drug ingestion Psychopharmacology 114 243 247 7838915 10.1007/BF02244844 1:STN:280:DyaK2M7ktVygtQ%3D%3D (Pubitemid 24152113)
50. K Silverman GK Mumford RR Griffiths 1994 Enhancing caffeine reinforcement by behavioral requirements following drug ingestion Psychopharmacology 114 424 432 7855200 10.1007/BF02249332 1:CAS:528:DyaK2cXjtFGksrk%3D (Pubitemid 24153491)
51. SL Simon K Richardson J Dacey S Glynn CP Domier RA Rawson W Ling 2002 A comparison of patterns of methamphetamine and cocaine use J Addict Dis 21 35 44 11831498 10.1300/J069v21n01-04 (Pubitemid 35203852)
52. WW Stoops JA Lile MT Fillmore PE Glaser CR Rush 2005 Reinforcing effects of methylphenidate: influence of dose and behavioral demands following drug administration Psychopharmacology 177 349 355 15609070 10.1007/s00213-004-1946-z 1:CAS:528:DC%2BD2cXhtVyltL3L (Pubitemid 40137296)
53. WW Stoops JA Lile MT Fillmore PE Glaser CR Rush 2005 Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration Psychopharmacology 182 186 193 15986191 10.1007/s00213-005-0044-1 1:CAS:528:DC%2BD2MXhtVOitb7N (Pubitemid 41400876)
54. ME Tancer CE Johanson 2001 The subjective effects of MDMA and mCPP in moderate MDMA users Drug Alcohol Depend 65 97 101 11714594 10.1016/S0376- 8716(01)00146-6 1:CAS:528:DC%2BD3MXosFKrurg%3D (Pubitemid 33063665)
55. M Tancer CE Johanson 2003 Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP Drug Alcohol Depend 72 33 44 14563541 10.1016/S0376-8716(03)00172-8 1:CAS:528: DC%2BD3sXotVylsLs%3D (Pubitemid 37255328)
56. FX Vollenweider A Gamma M Liechti T Huber 1998 Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naive healthy volunteers Neuropsychopharmacology 19 241 251 9718588 1:CAS:528:DyaK1cXlslWktb0%3D (Pubitemid 28491334)
57. Z Wang WL Woolverton 2007 Estimating the relative reinforcing strength of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine Psychopharmacology 189 483 488 17063335 10.1007/s00213-006-0599-5 1:CAS:528:DC%2BD28Xht1entL7K (Pubitemid 44791218)
58. K Wesnes DM Warburton 1983 Effects of smoking on rapid information processing performance Neuropsychobiology 9 223 229 6646394 10.1159/000117969 1:STN:280:DyaL2c%2FmvVGnsg%3D%3D (Pubitemid 13018097)